Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Device Maker Bets $525 Million on Recycling Medical Devices
WSJ Online
Monday, November 30, 2009 - 3:46pm
tags:
medical devices, Stryker, M&A, Ascent Healthcare Solutions
FDA Offers Pfizer's HIV Drug Selzentry New Life -- For All the Good It Will Do
BNET Pharma
Monday, November 30, 2009 - 3:40pm
tags:
Pfizer, HIV, FDA, Selzentry
Johnson & Johnson: Good & Bad News
TheStreet.com
Monday, November 30, 2009 - 3:36pm
tags:
JNJ, Revlimid, HIV, FDA, Tibotec
Abbott Laboratories grants Teva rights to cholesterol drug TriCor as early as March of 2011
Yahoo/AP
Monday, November 30, 2009 - 3:35pm
tags:
TriCor, Abbott Laboratories, Teva Pharmaceuticals, patents
Supreme Court hears case on whether shareholders waited too long to sue over Vioxx losses
Yahoo/AP
Monday, November 30, 2009 - 3:34pm
tags:
Vioxx, Merck
Drugs: Cost is the highest barrier for treatments
FT.com
Monday, November 30, 2009 - 3:33pm
tags:
drug costs, Pfizer, GSK
Genentech insists it hasn't lost its R&D mojo
Fierce Biotech
Monday, November 30, 2009 - 11:08am
tags:
R&D, Genentech, Roche
Sanofi reps await layoff news today
Fierce Pharma
Monday, November 30, 2009 - 11:06am
tags:
Sanofi, layoffs, drug reps, sales reps
Celgene Cancer Pill to Triple Sales on Threat to J&J
Bloomberg
Monday, November 30, 2009 - 11:05am
tags:
Celgene, JNJ, cancer, Revlimid, Velcade
Biotech Calendar: Key Dates for December
TheStreet.com
Monday, November 30, 2009 - 11:00am
tags:
Exelixis, Dyax, OSI Pharmaceuticals, Isis Pharmaceuticals, Somaxon, Gilead Sciences, Eli Lilly, Vion Pharmaceuticals, Roche, Immunogen, Auxilium, BioDelivery Sciences, Arena Pharmaceuticals, Vivus, Synta
BioMarin treatment gets special FDA status
Yahoo/AP
Monday, November 30, 2009 - 10:59am
tags:
FDA, Biomarin, orphan drugs
Drug stocks split; Theravance slides on FDA setback
Marketwatch
Monday, November 30, 2009 - 10:47am
tags:
FDA, Theravance, drug stocks
Great Opportunity for Incyte
Yahoo/Zacks.com
Monday, November 30, 2009 - 10:40am
tags:
Incyte, Novartis
AstraZeneca Moves Drug Production to China, Begging Safety Questions for FDA
BNET Pharma
Monday, November 30, 2009 - 10:37am
tags:
FDA, AstraZeneca, drug manufacturing, China, drug safety
Sequenom Stock Now the Plaything of Rumors
BNET Pharma
Monday, November 30, 2009 - 10:37am
tags:
Sequenom
Daiichi Sankyo's CEO: Soft-talking revolutionary
FT.com
Monday, November 30, 2009 - 10:35am
tags:
Pharma CEOs, Daiichi Sankyo, Takashi Shoda
Patent issued for Allos Therapeutics' cancer drug Folotyn
Bizjournals.com
Monday, November 30, 2009 - 10:33am
tags:
Allos, Folotyn, patents, lymphoma
Eli Lilly's Cymbalta gets additional FDA approval
Yahoo/AP
Monday, November 30, 2009 - 10:32am
tags:
FDA, generalized anxiety disorder, Cymbalta, Eli Lilly
Glaxo Sales Reps Are Denied Overtime By Court
Pharmalot
Monday, November 30, 2009 - 10:27am
tags:
GSK, drug reps, sales reps, overtime lawsuits
China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO
Seeking Alpha
Monday, November 30, 2009 - 10:25am
tags:
China, IPOs, Merck Serono, Pfizer, Gilead Sciences, GSK, Sinovac

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.